Hany Elmariah

22PUBLICATIONS
137CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 17, 2026
A novel severe toxicity-free, and progression-free survival endpoint predicts outcomes after CD19 chimeric antigen receptor-T cell therapy in large B-cell lymphoma.

|Jun 20, 2026
Expanded antigen-specific donor regulatory T cells for GVHD prevention.

|Feb 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.

Jakob Wirbel, Wael Saber, Michael J Martens

|Jan 26, 2026
Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation.

Luis E Aguirre, Haesook T Kim, Hany Elmariah

|Jul 05, 2025
Letermovir reduces cytomegalovirus in HLA-matched and mismatched allogeneic hematopoietic cell transplant patients receiving post-transplant cyclophosphamide.

Jena Schmitz, Eric Gaskill, Samantha Price

|Jun 10, 2025
Phase II Trial of Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With Haploidentical Donor Peripheral Blood Stem Cell Transplant.

Hany Elmariah, Jongphil Kim, Rebecca Gonzalez

Pageof 4

Frequent Collaborators

11 joint publications

Taiga Nishihori

11 joint publications

Nelli Bejanyan

6 joint publications

Jongphil Kim

6 joint publications

Michael Jain